Director/PDMR Shareholding

MGC Pharmaceuticals Limited

10 May 2023

 

MGC Pharmaceuticals Ltd.

PDMR Notification

10 May 2023

ASX, LSE: MXC

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') wishes to advise that the following Persons Discharging Managerial Responsibilities (PDMR) have dealt with shares in MGC Pharma, and this notification is made in accordance the UK Market Abuse Regulations.

The shares subject of this notice were issued to the PDMR as part of their working contracts and as consideration for services rendered in lieu of cash payments. In addition to the issue, there was also a disposal of shares by one PDMR.

Following the issue of these shares, the Company has 3,349,692,950 ordinary shares in issue, each with one voting right. Therefore, the Company's total number of ordinary shares in issue and voting rights is 3,349,692,950 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Amir Polak
2	Reason for the notification
(a)	Position		Chief Pharmaceutical Development Officer
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Disposal of shares
(d)	Currency	Price		Volume	Total
	AUD	$0.008		500,000	$4,000
	Aggregated information
	AUD	$0.008		500,000	$4,000
(e)	Date of transaction		1. 2023-05-04
(f)	Place of transaction		Australian Stock Exchange
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as consideration for services rendered
(d)	Currency	Price		Volume	Total
	AUD	$0.0107		7,209,112	$77,137
	Aggregated information
	AUD	$0.0107		7,209,112	$77,137
(e)	Date of transaction		2023-05-05
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Itay Nissim
2	Reason for the notification
(a)	Position		Chief Manufacturing and Supply Chain Officer
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as consideration for services rendered.
(d)	Currency	Price		Volume	Total
	AUD	$0.0107		6,946,963	$74,333
	Aggregated information
	AUD	$0.0107		6,946,963	$74,333
(e)	Date of transaction		2023-05-05
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Robert Clements
2	Reason for the notification
(a)	Position		Chief Commercial Officer
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as consideration for services rendered.
(d)	Currency	Price		Volume	Total
	AUD	$0.0107		7,537,673	$80,653
	Aggregated information
	AUD	$0.0107		7,537,673	$80,653
(e)	Date of transaction		2023-05-05
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Tom Cairns
2	Reason for the notification
(a)	Position		Chief Accounting Officer
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as consideration for services rendered.
(d)	Currency	Price		Volume	Total
	AUD	$0.0107		6,408,682	$68,573
	Aggregated information
	AUD	$0.0107		6,408,682	$68,573
(e)	Date of transaction		2023-05-05
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Yifat Steuer
2	Reason for the notification
(a)	Position		Chief Operating Officer and Deputy CEO
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as consideration for services rendered.
(d)	Currency	Price		Volume	Total
	AUD	$0.0107		11,359,813	$121,550
	Aggregated information
	AUD	$0.0107		11,359,813	$121,550
(e)	Date of transaction		2023-05-05
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Yair Tal
2	Reason for the notification
(a)	Position		Chief Information Security Officer
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as consideration for services rendered.
(d)	Currency	Price		Volume	Total
	AUD	$0.0107		7,078,038	$75,732
	Aggregated information
	AUD	$0.0107		7,078,038	$75,732
(e)	Date of transaction		2023-05-05
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Nicole Godress
2	Reason for the notification
(a)	Position		Global Chief Sales Officer MGC Medical
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as consideration for services rendered.
(d)	Currency	Price		Volume	Total
	AUD	$0.0107		876,636	$9,380
	Aggregated information
	AUD	$0.0107		876,636	$9,380
(e)	Date of transaction		2023-05-05
(f)	Place of transaction		Outside a trading venue

--Ends--

Authorised for release by the Managing Director, for further information please contact:

MGC Pharmaceuticals Ltd      Roby Zomer CEO & Managing Director [phone] [e-mail]	MGC Pharmaceuticals Ltd Arron Canicais / Rowan Harland Joint Company Secretaries [phone] [e-mail]
UK PR Advisors Tavistock Charles Vivian / Tim Pearson [phone] [e-mail]	UK Brokers Peterhouse Capital Charles Goodfellow / Lucy Williams [phone] [e-mail] / [e-mail]
UK Financial and Corporate Advisor SW4 Partners Rupert Fane / Nilesh Patel [e-mail]  / [e-mail]

 

END